Southeastern Pain and Wellness, PLLC

Southeastern Pain and Wellness, PLLC was paid $23K by Medicaid between Nov 2020 and Nov 2021, across 8 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 52% of everything it billed.

33Billing provider infoSOUTHEASTERN PAIN AND WELLNESS, PLLC
KING, NC 27021

33aNPI1992310502assigned 09/10/2020

33bProvider typeInterventional Pain Medicine Physician

28Total paid$23K

24GClaims2,040

24DCodes billed8

24AFirst – last monthNov 2020 – Nov 2021

Compared with peers

Next to other Interventional Pain Medicine Physician providers in North Carolina

Rank by total paid#9 of 16

Median peer was paid$23K

This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	71	$978.67
2021	1,969	$22K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	52%	578	287	$12K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	34%	270	175	$8K
99406		5.4%	348	156	$1K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	4.3%	71	26	$978.67
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	3.6%	33	21	$822.60
81025		1.3%	52	43	$286.65
1159F		<1%	531	254	$0.01
G9584	Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy	0%	157	122	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTUNNELL, DAVID (AO)